These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 12567457)

  • 21. Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.
    Zouali M; Eyquem A
    J Clin Immunol; 1984 May; 4(3):209-19. PubMed ID: 6610689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies and the autoimmune diseases.
    Josephson AS
    Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S; Avramescu C; Siloşi I; Drackoulogona O; Badea P; State A
    Oftalmologia; 2002; 54(3):51-5. PubMed ID: 12723199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Laboratory diagnosis of polysystemic autoimmune diseases].
    Sipka S
    Orv Hetil; 2005 Feb; 146(9):403-9. PubMed ID: 15830607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
    Radulescu D; Pripon S; Ciovicescu F; Constantea NA
    Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to hnRNP core protein A1 in connective tissue diseases.
    Astaldi Ricotti GC; Bestagno M; Cerino A; Negri C; Caporali R; Cobianchi F; Longhi M; Maurizio Montecucco C
    J Cell Biochem; 1989 May; 40(1):43-7. PubMed ID: 2745573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
    Zouali M; Jefferis R; Eyquem A
    Immunology; 1984 Mar; 51(3):595-600. PubMed ID: 6230310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G; Shovman O; Skriner K; Gilburd B; Langevitz P; Miholits M; Hoet R; Levy Y; Zandman-Goddard G; Hoefler E; Smolen JS; Shoenfeld Y
    Clin Exp Rheumatol; 2002; 20(4):517-24. PubMed ID: 12180437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies to extractable nuclear antigens in rheumatic diseases].
    Ivanova SM; Ivanova MM; Speranskiĭ AI
    Ter Arkh; 1980; 52(6):59-62. PubMed ID: 7404390
    [No Abstract]   [Full Text] [Related]  

  • 30. [Masking of pan-T-cell markers in patients with autoimmune diseases].
    Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
    Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
    [No Abstract]   [Full Text] [Related]  

  • 31. SLE or MCTD and the snurp in the splicing.
    Whittingham S
    J Rheumatol; 1990 Oct; 17(10):1260-2. PubMed ID: 1701487
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibodies to anticoagulants in rheumatic autoimmune diseases].
    Gromnica-Ihle E; Schössler W; Franz J; Ziemer S; Hüge H; Apostoloff E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):549-56. PubMed ID: 1714859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases.
    Bustin M; Reisch J; Einck L; Klippel JH
    Science; 1982 Mar; 215(4537):1245-7. PubMed ID: 6460317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase III: a new target for autoantibodies in autoimmune diseases.
    Robert-Pachot M; Desbos A; Moreira A; Becchi M; Tebib J; Bonnin M; Aitsiselmi T; Bienvenu J; Fabien N
    Autoimmunity; 2007 Jul; 40(5):380-9. PubMed ID: 17612900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.
    Ginsburg WW; Conn DL; Bunch TW; McDuffie FC
    J Rheumatol; 1983 Apr; 10(2):235-41. PubMed ID: 6864677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases.
    Skriner K; Hueber W; Süleymanoglu E; Höfler E; Krenn V; Smolen J; Steiner G
    Arthritis Rheum; 2008 Feb; 58(2):511-20. PubMed ID: 18240226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.